That this is a reasonable therapeutic approach comes from the recent demonstration that systemic administration of a recombinant NGB, with higher oxygen binding affinity and higher NO reduction capacity, is effective to prevent carbon monoxide poisoning (Azarov et al., 2016). Here, NGB is linked to carbon monoxide poisoning.